Semerjian Harout 4
4 · GLYCOMIMETICS INC · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Semerjian Harout
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-21+423,500→ 423,500 totalExercise: $1.11Exp: 2032-01-20→ Common Stock (423,500 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option will vest on January 21, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.